Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
- Advertisment -
Tags
N4 Pharma
Tag:
N4 Pharma
Shares
AIM movers: Shuka Minerals drawdown delayed and i3 Energy bid
Andrew Hore
-
20/08/2024
1
Shares
AIM movers: Bradda Head Lithium resource set to increase and Kibo Energy still falling
Andrew Hore
-
14/06/2024
0
Shares
AIM movers: Big Technologies loses contract and Oriole Resources signs second earn-in
Andrew Hore
-
19/01/2024
5
Shares
AIM movers: Microsaic Systems shares fall after consolidation and Eqtec draws down facility
Andrew Hore
-
16/01/2024
1
Shares
AIM movers: Poor fourth quarter for CMO and Oriole Resources receives earn-in payment
Andrew Hore
-
08/01/2024
0
Shares
AIM movers: Eden Research gains approval in Italy and Cap-XX patent defeat
Andrew Hore
-
18/12/2023
2
Shares
AIM movers: Bradda Head updates resource and ex-dividends
Andrew Hore
-
28/09/2023
0
Shares
AIM movers: Eckoh grows in North America and FireAngel delays
Andrew Hore
-
25/04/2023
0
Shares
AIM movers: Quantum Blockchain mining and another disappointment for IOG
Andrew Hore
-
18/01/2023
1
Shares
AIM weekly movers: Harland & Wolff gains Roayl Navy contract
Andrew Hore
-
19/11/2022
6
1
2
Page 1 of 2
Most Read
AIM moveres: SDX Energy postpones general meeting and Arecor Therapeutics licence deal
30/12/2024
Narf revenues decline as it changes focus to SocialCyber
30/12/2024
MicroSalt set to benefit from FDA’s new ‘healthy’ labelling rules
30/12/2024
Top 20 Stock Picks for 2025
30/12/2024